Zobrazeno 81 - 84
of 84
pro vyhledávání: '"Gino Cioffi"'
Autor:
Asrar Alahmadi, Ankit Mangla, David L. Bajor, David B. Mansur, Patrick J Getty, Joel N. Saltzman, Prantesh Jain, Aashish D. Bhatt, Gino Cioffi, John B. Ammori, Richard T. Lee, Nirav Patil, Aman Opneja
Publikováno v:
Journal of Clinical Oncology. 38:498-498
498 Background: Primary liver angiosarcoma (LAS) is a rare and aggressive tumor of the liver. In this analysis of the national cancer database (NCDB) we sought the risk of mortality and factors associated with survival amongst patient diagnosed with
Autor:
Joel N. Saltzman, David L. Bajor, Asrar Alahmadi, Richard T. Lee, Gino Cioffi, Aman Opneja, Jill S. Barnholtz-Sloan, Nirav Patil
Publikováno v:
Journal of Clinical Oncology. 37:e15682-e15682
e15682 Background: HCC is a common cause of mortality in the U.S. among men and women (5thand 7th, respectively) with overall five-year survival of ~18%. Sorafenib was the only FDA approved therapy for advanced HCC from 2007 until 2018. This study an
Autor:
Richard T. Lee, Aman Opneja, David L. Bajor, Asrar Alahmadi, Jill S. Barnholtz-Sloan, Nirav Patil, Gino Cioffi, Joel N. Saltzman
Publikováno v:
Journal of Clinical Oncology. 37:e15686-e15686
e15686 Background: BTC has a limited prognosis even for localized cancers (15-30% 5-year survival) emphasizing the importance of multidisciplinary management. NCCN guidelines recommend adjuvant chemotherapy (CT) +/- radiotherapy (RT) for high risk di
Autor:
Benita K. Glamour, Prasad G. Iyer, Julian A. Abrams, Gary W. Falk, Amitabh Chak, Nicholas J. Shaheen, Joseph Willis, Jean S. Wang, Wendy Brock, Apoorva K. Chandar, Omar A. Alaber, Marcia I. Canto, Gino Cioffi, Kishore Guda, William M. Grady, Sanford D. Markowitz, Andrew Blum, Prashanthi N. Thota, Jill S. Barnholtz-Sloan
Publikováno v:
Gastroenterology. 156:S-287